Individuals living with type 1 diabetes (T1D) from medically underserved communities have poorer health outcomes. Efforts to improve outcomes include a focus on team-based care, activation of behavior change, and enhancing self-management skills and practices. Advanced diabetes technologies are part of the standard of care for adults with T1D. However, health care providers often carry implicit biases and may be uncomfortable with recommending technologies to patients who have traditionally been excluded from efficacy trials or have limited real-world exposure to devices. We review the literature on this topic and provide an approach to address these issues in clinical practice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ecl.2023.07.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!